Clinical Trial Update: Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children

View source ↗

Summary

A completed clinical trial evaluating immune heterogeneity before and after cardiopulmonary bypass in children with ventricular septal defect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Septal Defect

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Ventricular Septal Defect | Status: COMPLETED